One page, thousands of outlets. See who else covered it.
(MedPage Today) -- Use of active surveillance for low- and favorable intermediate-risk prostate cancer more than tripled since 2005, according to a large study of veterans. In 2005 active surveillance accounted for 27% of men with low-risk prostate...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
Outdated state laws are threatening Nigeria’s disease outbreak preparedness, warns NCDC. Learn how weak public health laws undermine national response effo Read More…
The Borno government has received life-saving cholera and reproductive kits worth millions of naira, donated by Plan International Nigeria, to read more Borno govt receives cholera, reproductive kits…
St. Jude CEO Dr. Charles W. M. Roberts said he believes this is a "once-in-a-lifetime opportunity" to achieve the dream of treating cancer in children.
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.
Moderna and Merck said the personalised vaccine reduced the risk of recurrence and spread of melanoma in a late-stage trial, a major success in a new field of cancer treatment.
